glp-1 receptor agonists should be avoided in patients with – Peripheral Brain New MHRA warning on the
Description
At present, the studies of EX on non-diabetic obesity mainly include 152 cases of simple obesity (weight loss of 5.1 kg) (54), 60 cases of polycystic ovary syndrome (weight loss of 3.2-6.0 kg) (55), and 10 cases of metabolic syndrome (weight loss of 3.7 kg) (56), among which the most common adverse reaction is still vomiting
95% CI: 0.89-1.17)
(13) Disruption of this balancesuch as elevated RANKL or reduced OPGis linked to increased bone resorption and delayed fracture healing, particularly in diabetes
Diabetes Care 40 , 6976 (2017)
J Diabetes Investig (2015) 6:2019
